Spread and Course of COVID-19 Infections (CoV-ETH)

Goldhahn Jörg

Status: Completed

Conditions: Covid-19; Virus Disease

Study type: Observational

Funder types: Other

Identifiers

NCT04377724

20-05

Details and patient eligibility

About

The overall goal is to study the immune response to SARS-CoV-2 infection over the period of one year in the blood of a representative cohort of ETH students/employees.

Enrollment: 2,910 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• ETH employee or ETH student and their family members living in the same household at the start of the study
• Between 18 and 64 years of age at the start of the study
• Signed informed consent

Exclusion criteria

• Age over 64 years at the start of the study

• In quarantine or self-confinement at the start of the study

• Active COVID-19 infection at the start of the study:

  • Diagnosed with a laboratory test
  • Suspected based on typical symptoms such as fever (>38°C), acute pulmonary ex-acerbation or sudden loss of gustatory taste

• The following medical condition

  • With continuous steroid therapy/ chemotherapy/immunsuppressive therapy
  • In treatment for cancer
  • With severe autoimmune disease

Trial design

2,910 participants in 1 patient group

ETH cohort

Description:

employees or students at ETH Zurich, Switzerland